Page last updated: 2024-11-10

diethyl maleate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

diethyl maleate : A maleate ester resulting from the formal condensation of both carboxy groups of maleic acid with ethanol. A colourless liquid at room temperature (m.p. -10degreeC) with boiling point 220degreeC at 1 atm., it is commonly used as a dienophile for Diels-Alder-type cycloaddition reactions in organic synthesis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5271566
CHEMBL ID2037000
CHEBI ID68508
SCHEMBL ID60423
MeSH IDM0062997

Synonyms (74)

Synonym
2-butenedioic acid (2e)-, 1,4-diethyl ester
2-butenedioic acid (z)-, diethyl ester
maleic acid, diethyl ester
diethyl maleate
nsc-8394
nsc8394
wln: 2ov1u1vo2
141-05-9
diethylmaleate
trans-2-butenedioic acid diethyl ester
2-butenedioic acid(e)-,diethyl ester
ccris 941
diethylester kyseliny maleinove [czech]
brn 1100825
einecs 205-451-9
2-butenedioic acid (2z)-, diethyl ester
nsc 8394
ai3-00678
diethyl (z)-but-2-enedioate
2-butenedioic acid, diethyl ester, (z)-
2-butenedioic acid, diethyl ester, (2z)-
diethyl (2z)-but-2-enedioate
diethyl maleate, 97%
diethyl maleate, >=96%, fg
maleic acid diethyl ester
M0010
A807721
diethyl (z)-but-2-enedioate;diethyl maleate
NCGC00249057-01
dtxsid8020464 ,
tox21_303020
NCGC00256390-01
dtxcid80464
cas-141-05-9
NCGC00259062-01
tox21_201512
68988-24-9
CHEMBL2037000
S4712
AKOS015960830
2-butenedioic acid (2z)-, 1,4-diethyl ester
ec 205-451-9
4-02-00-02207 (beilstein handbook reference)
unii-g81wqb56ol
diethylester kyseliny maleinove
g81wqb56ol ,
CHEBI:68508 ,
(2z)-2-butenedioic acid, 1,4-diethyl ester
diethyl maleate [mi]
diethyl (z)-2-butenedioate
staflex dem
SCHEMBL60423
diethyl (2z)-2-butenedioate #
diethyl ester of (e)-2-butenedioic acid
diethyl (2e)-2-butenedioate
mfcd00009191
1,4-diethyl (2z)-but-2-enedioate
F1908-0131
fumaric acid, diethyl ester (8ci)
diethyl ester(e)-2-butenedioic acid
2-butenedioic acid (e)-, diethyl ester (9ci)
diethyl ester(2e)-2-butenedioic acid
diethyl maleate, analytical standard
Z3234965665
BS-15532
diethyl-2-butenedioate
Q1646591
AMY3405
CCG-266368
D70233
diethyl maleate 100 microg/ml in acetonitrile
CS-0017148
HY-Y1147
EN300-344747

Research Excerpts

Toxicity

DL-Buthionine-[S,R]-Sulfoximine (BSO) and Diethyl maleate (DEM) were used to potentiate the toxic effect of the bipyridyl.majus) methyl alcohol extract and vitamin E.

ExcerptReferenceRelevance
" The resulting dose-response curves obtained with CHO/DEM and control CHO cells indicated that chronic exposure to DEM, which resulted in chronic elevation of glutathione, did not provide protection against any of the three toxic treatments."( Failure of chronic glutathione elevation to reduce cytotoxicity produced by exposure to cis-diamminedichloroplatinum(II), ionizing radiation, or hyperthermia.
Eisert, DR; Freeman, ML; Meredith, MJ, 1990
)
0.28
" We propose that m-dinitrobenzene requires metabolic activation before it can exert its toxicity to Sertoli cells, and it appears that the toxic species is m-nitrosonitrobenzene or a further metabolite of m-nitrosonitrobenzene."( Modulation of m-dinitrobenzene and m-nitrosonitrobenzene toxicity in rat Sertoli--germ cell cocultures.
Cave, DA; Foster, PM, 1990
)
0.28
" Addition of high concentrations of catalase, but not superoxide dismutase, to the incubations provided some protection against the toxic effect of diquat, but much better protection was observed when catalase was added in combination with the iron chelator desferrioxamine."( Cytotoxicity of the redox cycling compound diquat in isolated hepatocytes: involvement of hydrogen peroxide and transition metals.
Moldeus, P; Ross, D; Sandy, MS; Smith, MT, 1987
)
0.27
" Coumarin also produced time- and dose-dependent toxic effects in primary rat hepatocyte cultures."( Studies on the mechanism of coumarin-induced toxicity in rat hepatocytes: comparison with dihydrocoumarin and other coumarin metabolites.
Beamand, JA; Evans, JG; Gray, TJ; Hue, KL; Lake, BG; Lewis, DF, 1989
)
0.28
" The 14-day LD50 for a single ip dose of helenalin in male mice was 43 mg/kg."( Acute toxicity of helenalin in BDF1 mice.
Chaney, SG; Chang, J; Chapman, DE; Grippo, AA; Hall, IH; Holbrook, DJ; Lee, KH; Reynolds, DJ; Roberts, GB, 1988
)
0.27
" Yet neither substance protected mice from the toxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons, as shown by marked depletion of striatal dopamine content when animals were sacrificed."( Manipulation of glutathione contents fails to alter dopaminergic nigrostriatal neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
Jones, K; Perry, TL; Wright, JM; Yong, VW, 1986
)
0.27
" Previous studies have demonstrated that a toxic metabolite contributes to or is responsible for acute NDPS-induced nephrotoxicity."( Role of glutathione in acute N-(3,5-dichlorophenyl) succinimide-induced nephrotoxicity in Sprague-Dawley and Fischer 344 rats.
Bolton, B; Brown, PI; Rankin, GO; Teets, VJ; Yang, DJ, 1987
)
0.27
" Whereas a toxic dose of acetaminophen administration did not effect SGOT and SGPT levels after 30 hr in PTU pretreated rats given either a single or multiple injections of DEM, the same dose of acetaminophen in the control rats raised these transaminases to a very high level."( Prevention of acetaminophen hepatotoxicity by propylthiouracil in the glutathione depleted rat.
Cho, C; Linscheer, WG; Raheja, KL, 1983
)
0.27
" These data support the concept that phosgene is the toxic intermediate in chloroform metabolism."( Effect of cysteine, diethyl maleate, and phenobarbital treatments on the hepatotoxicity of [1H]chloroform.
Anders, MW; Stevens, JL, 1981
)
0.26
" This suggests that the final transforming activity response is dependent on the intracellular GSH-mediated mechanism of reduction of vanadium(V) to vanadium(IV): (i) the extent to which vanadium(V) should be bioreduced to less toxic vanadium(IV) via intracellular GSH is a key point in determining the intensity of the observed neoplastic action; (ii) the carcinogenic potential of vanadium(V) should be strictly dependent on its intracellular persistence which could lead to changes in normal metabolic patterns of vanadium(V) in the oxidized form due to lack of GSH-mediated reduction."( The intensity of vanadium(V)-induced cytotoxicity and morphological transformation in BALB/3T3 cells is dependent on glutathione-mediated bioreduction to vanadium(IV).
Casella, L; Devos, S; Fischbach, M; Pintar, A; Pozzi, G; Sabbioni, E, 1993
)
0.29
" Prednisolone pretreatment resulted in decreased covalent binding of the toxic metabolite in vivo and an increased urinary excretion of glutathione-derived conjugates of acetaminophen, indicating an enhanced detoxification of the reactive metabolite by glutathione."( Prednisolone stimulates hepatic glutathione synthesis in mice. Protection by prednisolone against acetaminophen hepatotoxicity in vivo.
Lauterburg, BH; Schranz, C; Speck, RF, 1993
)
0.29
" Results from these studies suggested that a highly toxic arene oxide intermediate of 4-bromobenzene formed as the result of mixed function oxidase (MFO)-mediated metabolism may play an important role in the development toxicity of 4-bromobenzene in vitro."( Evaluation of the developmental toxicity of 4-bromobenzene using frog embryo teratogenesis assay--Xenopus: possible mechanisms of action.
Fort, DJ; Propst, TL; Stover, EL, 1996
)
0.29
" DL-Buthionine-[S,R]-Sulfoximine (BSO) and Diethyl maleate (DEM) were used to potentiate the toxic effect of the bipyridyl."( Biochemical studies on the toxicity of 1, 1'-dimethyl-4, 4'-bipyridylium dichloride in the rat.
Nwabisi, VC; Nwanze, EA, 1997
)
0.3
"majus) methyl alcohol extract and vitamin E in the case of toxic effect induced by diethyl maleate was evaluated."( The protective role of Tropaeolum majus on blood and liver toxicity induced by diethyl maleate in rats.
Arbid, MS; El-Gendy, NF; Koriem, KM, 2010
)
0.36
" Taken collectively, these results indicate that pretreatment with NAC ameliorates (a) mitochondrial dysfunction linked to the depletion of ATP, MMP, and mitochondrial GSH level and (b) induction of oxidative stress assessed by reactive oxygen species generation, losses of intracellular GSH and protein thiol levels, and MDA formation caused by C60(OH)24, suggesting that the onset of toxic effects is at least partially attributable to a thiol redox-state imbalance as well as mitochondrial dysfunction related to oxidative phosphorylation."( Effects of N-acetyl-L-cysteine on target sites of hydroxylated fullerene-induced cytotoxicity in isolated rat hepatocytes.
Inomata, A; Nakae, D; Nakagawa, Y; Nakajima, K; Ogata, A; Suzuki, T, 2014
)
0.4

Pharmacokinetics

ExcerptReferenceRelevance
" Diethylmaleate pretreatment decreased the total clearance and increased the half-life of acetaminophen."( Role of glutathione turnover in drug sulfation: differential effects of diethylmaleate and buthionine sulfoximine on the pharmacokinetics of acetaminophen in the rat.
Galinsky, RE, 1986
)
0.27

Compound-Compound Interactions

ExcerptReferenceRelevance
" When DEM was combined with MISO (100 mg/kg), ER's of the combination were larger than that of MISO alone, for doses over 400 mg/kg of DEM."( The radiosensitizing effects of misonidazole (MISO) in combination with diethyl maleate (DEM) in mouse mammary tumors.
Abe, M; Dodo, Y; Komuro, C; Nishidai, T; Ono, K; Shibamoto, Y; Shrieve, DC; Takahashi, M, 1986
)
0.27

Bioavailability

ExcerptReferenceRelevance
"Absorption promoters, or adjuvants, are used to enhance the gastrointestinal absorption of poorly absorbed drugs such as macromolecules."( The reversibility of absorption promoter interaction with red blood cell membranes studied with differential scanning calorimetry.
Ando, HY; Holinej, J; Snow, JW, 1988
)
0.27

Dosage Studied

Pretreatment with extracellular GSH caused a right shift of the dose-response curve for NH2Cl, whereas pretreatment with diethyl maleate (a depletor of cellular GSH) rendered cells less resistant toNH2Cl. Hepatic lesions were seen in hamsters and were more frequent and severe in gerbils that were treated with diet hl maleate prior to rubratoxin B.

ExcerptRelevanceReference
" The resulting dose-response curves obtained with CHO/DEM and control CHO cells indicated that chronic exposure to DEM, which resulted in chronic elevation of glutathione, did not provide protection against any of the three toxic treatments."( Failure of chronic glutathione elevation to reduce cytotoxicity produced by exposure to cis-diamminedichloroplatinum(II), ionizing radiation, or hyperthermia.
Eisert, DR; Freeman, ML; Meredith, MJ, 1990
)
0.28
" Dose-response curves were obtained using cells irradiated in the absence or presence of DEM/BSO, which decreased GSH levels by 90-95%."( Depletion of glutathione after gamma irradiation modifies survival.
Eisert, DR; Freeman, ML; Meredith, MJ; Saunders, EL, 1991
)
0.28
" We successfully employed ESR to detect the formation of the 5,5-dimethyl-1-pyrroline-N-oxide (DMPO)/hemoglobin thiyl free radical adduct in the blood of rats dosed with DMPO and tert-butyl hydroperoxide, cumene hydroperoxide, ethyl hydrogen peroxide, 2-butanone hydroperoxide, 15(S)-hydroperoxy-5,8,11,13-eicosatetraenoic acid, or hydrogen peroxide."( In vivo thiyl free radical formation from hemoglobin following administration of hydroperoxides.
Jordan, SJ; Kennedy, CH; Maples, KR; Mason, RP, 1990
)
0.28
"5 and 28 mg/kg), increased AF hepatotoxicity (10-fold shift in the dose-response effect on SGPT)."( Mechanism of allyl formate-induced hepatotoxicity in rainbow trout.
Davis, ME; Droy, BF; Hinton, DE, 1989
)
0.28
" One hr later they were dosed orally with 0, 250, 500 or 1000 mg TBZ/kg."( Glutathione and cysteine enhance and diethylmaleate reduces thiabendazole teratogenicity in mice.
Fujitani, T; Ogata, A; Sasaki, M; Suzuki, K; Yoneyama, M, 1989
)
0.28
" Analysis of thermal dose-response curves for cells exposed to between 10 and 100 microM DEM indicated that cell survival was unaffected by the addition of DEM until a critical concentration was surpassed."( Subcellular localization of glutathione and thermal sensitivity.
Freeman, ML; Meredith, MJ, 1988
)
0.27
" Additionally, hepatic lesions were seen in hamsters and were more frequent and severe in gerbils that were treated with diethyl maleate prior to rubratoxin B dosing compared to animals given rubratoxin B alone."( Reduction of hepatic and renal nonprotein sulfhydryl content and increased toxicity of rubratoxin B in the Syrian hamster and Mongolian gerbil.
Carlson, GP; Carlton, WW; Engelhardt, JA; Hayes, AW, 1988
)
0.27
" At the higher dosage of harmol, phorone reduced the biliary excretion of harmol sulfate while increasing the biliary excretion of harmol glucuronide."( Effect of glutathione depletion on sulfate activation and sulfate ester formation in rats.
Gregus, Z; Howell, S; Klaassen, CD; White, C, 1988
)
0.27
" Analysis of dose-response curves indicated that GSH depletion affected thermal sensitization and thermal radiosensitization at 42 degrees when greater than 95% of the GSH had been depleted."( The effect of GSH depletion on thermal radiosensitization.
Freeman, ML; Meredith, MJ, 1987
)
0.27
" and the circulating blood levels of intact and denitrosated compound 5 min after dosing quantified."( Evidence for cytosolic glutathione transferase-mediated denitrosation of nitrosocimetidine and 1-methyl-2-nitro-1-nitrosoguanidine.
Jensen, DE; Stelman, GJ, 1987
)
0.27
" Kidneys from hamsters treated with the GSH synthesis inhibitor L-buthionine-(S,R)-sulfoximine at a dosage of 1 mmol/kg body wt for 2 hr had 45% of the NP-SH content as compared with kidneys of saline-treated controls."( Glutathione protection against irreversible binding of diethylstilbestrol in the hamster renal cortex.
Adams, SP; Notides, AC, 1987
)
0.27
" To test whether inhibition of protein synthesis was related to GSH depletion, groups of animals were dosed with the alpha, beta-unsaturated carbonyl phorone (diisopropylidenacetone) or the specific inhibitor of GSH synthesis, buthionine sulfoximine (BSO)."( Effect of diethylmaleate and other glutathione depletors on protein synthesis.
Costa, LG; Murphy, SD, 1986
)
0.27
"3 mumol/g of liver and a slight increase in macromolecular adduct levels, the dose-response curve for macromolecular adduct formation remained linear in both diethyl maleate-pretreated and control groups."( Linear dose-response curve for the hepatic macromolecular binding of aflatoxin B1 in rats at very low exposures.
Appleton, BS; Campbell, TC; Goetchius, MP, 1982
)
0.26
" Renal glutathione was far more susceptible to the initial rapid depleting effects of ortho-bromophenol than was hepatic glutathione, the dose-response curve for hepatic glutathione depletion being shifted to the right."( The role of ortho-bromophenol in the nephrotoxicity of bromobenzene in rats.
Gillette, JR; Greene, KE; Lau, SS; Monks, TJ, 1984
)
0.27
" The rats were then given a calculated LD50 dosage (13."( Toxicologic study of carboxyatractyloside (active principle in cocklebur--Xanthium strumarium) in rats treated with enzyme inducers and inhibitors and glutathione precursor and depletor.
Clark, JD; Hatch, RC; Jain, AV; Weiss, R, 1982
)
0.26
" A dose-response relation was seen when sensitized human subjects were challenged with dihydrocoumarin, alantroot oil and diethylmalleate."( Further studies of effects of vehicles and elicitation concentration in experimental contact sensitization testing in humans.
Maibach, HI; Marzulli, FN, 1980
)
0.26
" The dose-response relationship indicated that the translocase was the most susceptible to hydrogen peroxide among the three enzymes studied."( Effects of hydrogen peroxide on mitochondrial enzyme function studied in situ in rat heart myocytes.
Kako, KJ; Tatsumi, T,
)
0.13
" Pretreatment with extracellular GSH caused a right shift of the dose-response curve for NH2Cl, whereas pretreatment with diethyl maleate (a depletor of cellular GSH) rendered cells less resistant to NH2Cl."( Monochloramine-induced cytolysis to cultured rat gastric mucosal cells: role of glutathione and iron in protection and injury.
Hiraishi, H; Ishida, M; Shimada, T; Terano, A; Yajima, N; Yamaguchi, N, 1999
)
0.3
" A similar dose-response relationship was seen with TR in A549 cells exposed to acrolein."( Effect of acrolein and glutathione depleting agents on thioredoxin.
Choi, YE; Kehrer, JP; Kern, JC; Wu, X; Yang, X, 2004
)
0.32
" In the dose-response experiment, ACN accelerated the conversion of XD to XO, with a significant depletion of gastric GSH in a dose-related manner."( Acrylonitrile-induced gastric toxicity in rats: the role of xanthine oxidase.
Al-Abbasi, FA, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
glutathione depleting agentA compound which causes a reduction in the levels of glutathione in cells.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
maleate esterCompounds of the general formula ROOC-CH=CH-COOR' where R and R' are organyl groups
ethyl esterAny carboxylic ester resulting from the formal condensation of the carboxy group of a carboxylic acid with ethanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency66.04920.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.21690.001530.607315,848.9004AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency13.38720.000229.305416,493.5996AID743075
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency0.69180.001024.504861.6448AID743227
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.00190.023723.228263.5986AID743223
thyrotropin-releasing hormone receptorHomo sapiens (human)Potency0.04260.154917.870243.6557AID1346877
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency18.99200.000627.21521,122.0200AID743202; AID743219
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency76.95880.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency76.95880.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (18)

Processvia Protein(s)Taxonomy
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (22)

Assay IDTitleYearJournalArticle
AID1136570Antifungal activity against Candida albicans ATCC 10231 at <100 ug/ml at pH 7 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136546Antifungal activity against Aspergillus niger ATCC 1004 at <100 ug/ml at pH 7 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136552Antifungal activity against Mucor mucedo ATCC 7941 at <100 ug/ml at pH 7 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136557Antifungal activity against Trichophyton mentagrophytes ATCC 9129 at pH 5.6 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136564Antifungal activity against Candida albicans ATCC 10231 at <100 ug/ml at pH 5.6 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136550Antifungal activity against Mucor mucedo ATCC 7941 at <100 ug/ml at pH 5.6 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136548Antifungal activity against Mucor mucedo ATCC 7941 at <100 ug/ml at pH 5.6 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1110853Synergism factor, ratio of LC50 for Tetranychus urticae LS-VL (two-spotted spider mite) larvae to LC50 for Tetranychus urticae LS-VL larvae in presence of 200 mg/L GSH depleter, DEM2009Pest management science, Apr, Volume: 65, Issue:4
Genetic and biochemical analysis of a laboratory-selected spirodiclofen-resistant strain of Tetranychus urticae Koch (Acari: Tetranychidae).
AID1110856Insecticidal activity against Tetranychus urticae LS-VL (two-spotted spider mite) larvae reared under continuous pressure of 5000 mg/L spirodiclofen for 5 months assessed as mortality treated 3-4 hr after 200 mg/L GSH depleter, DEM application measured af2009Pest management science, Apr, Volume: 65, Issue:4
Genetic and biochemical analysis of a laboratory-selected spirodiclofen-resistant strain of Tetranychus urticae Koch (Acari: Tetranychidae).
AID1110850Insecticidal activity against Tetranychus urticae SR-VP (two-spotted spider mite) larvae reared under continuous pressure of 5000 mg/L spirodiclofen for 5 months assessed as mortality treated 3-4 hr after 200 mg/L GSH depleter, DEM application measured af2009Pest management science, Apr, Volume: 65, Issue:4
Genetic and biochemical analysis of a laboratory-selected spirodiclofen-resistant strain of Tetranychus urticae Koch (Acari: Tetranychidae).
AID1136559Antifungal activity against Trichophyton mentagrophytes ATCC 9129 at pH 7 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136572Antifungal activity against Aspergillus niger ATCC 1004 at <100 ug/ml at pH 5.6 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID665153Cytoprotective activity against DEM-induced ROS production in human CEM cells assessed as cells with intact mitochondrial potential pretreated for 16 hrs prior DEM challenge measured after 120 mins by TMRM-based flow cytometry (Rvb = 94%)2012Bioorganic & medicinal chemistry, Jun-01, Volume: 20, Issue:11
Simplified bicyclic pyridinol analogues protect mitochondrial function.
AID1136542Antifungal activity against Aspergillus niger ATCC 1004 at <100 ug/ml at pH 5.6 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136568Antifungal activity against Candida albicans ATCC 10231 at <100 ug/ml at pH 7 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136566Antifungal activity against Candida albicans ATCC 10231 at <100 ug/ml at pH 5.6 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136554Antifungal activity against Mucor mucedo ATCC 7941 at <100 ug/ml at pH 7 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136561Antifungal activity against Trichophyton mentagrophytes ATCC 9129 at pH 7 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1110847Synergism factor, ratio of LC50 for Tetranychus urticae SR-VP (two-spotted spider mite) larvae to LC50 for Tetranychus urticae SR-VP larvae in presence of 200 mg/L GSH depleter, DEM2009Pest management science, Apr, Volume: 65, Issue:4
Genetic and biochemical analysis of a laboratory-selected spirodiclofen-resistant strain of Tetranychus urticae Koch (Acari: Tetranychidae).
AID1136555Antifungal activity against Trichophyton mentagrophytes ATCC 9129 at pH 5.6 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1110844Resistance ratio of LC50 for Tetranychus urticae SR-VP (two-spotted spider mite) larvae reared under continuous pressure of 5000 mg/L spirodiclofen for 5 months in presence of 200 mg/L GSH depleter, DEM to LC50 for Tetranychus urticae LS-VL (two-spotted s2009Pest management science, Apr, Volume: 65, Issue:4
Genetic and biochemical analysis of a laboratory-selected spirodiclofen-resistant strain of Tetranychus urticae Koch (Acari: Tetranychidae).
AID1136544Antifungal activity against Aspergillus niger ATCC 1004 at <100 ug/ml at pH 7 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (712)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990264 (37.08)18.7374
1990's242 (33.99)18.2507
2000's138 (19.38)29.6817
2010's61 (8.57)24.3611
2020's7 (0.98)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.13%)5.53%
Reviews3 (0.40%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other737 (99.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]